Medical Express

ISSN (print): 2318-8111

ISSN (online): 2358-0429

Issue: 4.5 - 6 Articles

Back to summary

x

How to cite


 

Ponciano S, Sampaio-Maia B, Areias C. Oral manifestations in children with mucopolysaccharidosis. MEDICALEXPRESS 2017;4(5):M170503 http://www.dx.doi.org/10.5935/MedicalExpress.2017.05.04

 

ORIGINAL RESEARCH http://www.dx.doi.org/10.5935/MedicalExpress.2017.05.04

Oral manifestations in children with mucopolysaccharidosis

Sara Ponciano1; Benedita Sampaio-Maia2; Cristina Areias3

1. University of Porto, Faculty of Dental Medicine, Porto, Portugal. University of Porto
2. University of Porto, Faculty of Dental Medicine, Nephrology and Infectious Diseases Research and Development Group, Instituto Nacional de Engenharia Biológica (INEB), Instituto de Investigação e Inovação em Saúde (I3S), Porto, Portugal
3. University of Porto, Faculty of Dental Medicine, Department of Odontopediatrics, Porto, Portugal

E-mail: sararodrip@gmail.com

Received in June 27 2017.
First Review in August 5 2017.
Accepted in September 11 2017.

Abstract

BACKGROUND: Patients with mucopolysaccharidosis have several changes of the stomatognathic complex, representing a challenge for dentists.
OBJECTIVE: The study aimed to evaluate and characterize oral health in patients with mucopolysaccharidosis in a reference center of Portugal.
METHOD: The sample consisted of twelve participants with mucopolysaccharidosis followed in Metabolic Diseases Unit of the S. João Hospital Centre and twelve healthy participants followed at Faculty of Dental Medicine, University of Porto. The clinical oral evaluation was performed by a complete extra-oral and intra-oral examination to assess the presence of oral pathologies, gingival index and occlusion status.
RESULTS: Mucoplysaccaridosis patients and controls presented similar age ranges and sex distribution. In comparison to controls, children with mucopolysaccharidosis presented a higher prevalence of tooth decay, gingival bleeding, macroglossia, dental hypoplasia, lingual interposition, delayed tooth eruption, anterior open bite, right and left posterior cross-bite, limitation of mouth opening, alteration on the size and shape of the teeth, diastemata and maxillary compression.
CONCLUSIONS: Patients with mucopolysaccharidosis have a high prevalence eruption delay, teeth morphology alterations, occlusal problems, dental caries and bleeding gums, highlighting the need of oral health care providers to improve diagnostics and preventive protocols to overcome the factors that limit the oral health of these patients and promote together with parent/caregiver efficient oral care strategies.

Keywords: Mucopolysaccharidosis, oral health, pediatrics, dental manifestations

Resumo

INFORMAÇÕES GERAIS: Os pacientes com mucopolissacaridose apresentam diversas alterações do complexo estomatognático, representando um desafio para os médicos dentistas.
OBJETIVO: O estudo pretendeu avaliar e caracterizar a saúde oral em pacientes com mucopolissacaridose num centro de referência em Portugal.
MÉTODO: A amostra foi constituída por doze pacientes com mucopolissacaridose (MPS) seguidos na Unidade de Doenças Metabólicas do Centro Hospitalar de São João e doze participantes saudáveis seguidos na Faculdade de Medicina Dentária da Universidade do Porto. A avaliação clínica oral consistiu num completo exame extra-oral e intra-oral para avaliação de patologias orais, índice gengival e perfil oclusal.
RESULTADOS: Pacientes com MPS e controlos apresentaram médias similares de idade e de distribuição de género. Em comparação com os controlos, crianças com mucopolissacaridose apresentam maior prevalência de dentes cariados, sangramento gengival, macroglossia, hipoplasia dentária, interposição lingual, erupção dentária atrasada, mordida aberta anterior, mordida cruzada posterior direita e esquerda, limitação da abertura da boca, alteração do tamanho e forma dentária, diastemas e compressão maxilar.
CONCLUSÃO: Pacientes com mucopolissacaridose apresentam maior prevalência de erupção dentária atrasada, alterações morfológicas dentárias, problemas oclusais, cáries dentárias e gengivas inflamadas, reforçando a necessidade de prestadores de saúde oral para melhorar diagnósticos e protocolos preventivos para ultrapassar os fatores que limitam a saúde oral destes pacientes e promover em conjunto com pais/cuidadores estratégias de saúde oral eficientes.

Palavras-chave: Mucopolissacaridose; saúde oral, pediatria, manifestações dentárias.

 

INTRODUCTION

Mucopolysaccharidosis (MPS) are a heterogeneous group of genetic disorders that can affect brain, eyes, oral cavity, face and skeleton, among other systems;1-6 they are lysosomal storage disorders caused by deficiency of the enzymes responsible for the degradation of glycosaminoglycans, causing the accumulation of these macromolecules in the lysosome present in various tissues and organs. The intracellular and extracellular accumulation of these non-metabolized substances causes dysfunction in multiple organs and systems.1-6

MPS are classified into seven major groups (I, II, III, IV, VI, VII, IX) according to the deficient enzyme and the accumulated substrate.1,7 Type II is linked to chromosome X, whereas all the others are autosomal recessive disorders.1,8,9 It is estimated that the overall incidence of MPS is around 4 per100,000 live births (0.04%).10-12

Each type of MPS is associated with a wide range of clinical heterogeneities; however, all possess some common characteristics such as multisystemic, chronic and progressive deterioration, with osteoarticular, audiovisual and cardiovascular changes. Mental retardation is rare in types IV and VI. Patients may appear normal at birth and manifest symptoms later.1-4,6-9,13-15 Among the various features that characterize MPS patients, the most common are dwarfism, umbilical and inguinal hernias, macrocephaly, coarse facial changes, delayed motor skills, corneal clouding, glaucoma, dysostoses, bone dysplasias, heart disease, respiratory distress (obstructive/restrictive disease), hepatosplenomegaly, progressive neurodegenerative disease, limited joint mobility as well as hearing loss.1-4,6-9,13-15

The average life expectancy in the most severe forms is between ten to twenty years, though in attenuated forms survival may be normal.1-4,6-9,13-15 Death is usually a result of either respiratory tract infection or cardiac disease, which are caused by the deposition of mucopolysaccharides.1-4,6,15,16 Diagnosis and management are often challenging because of the considerable variability in symptom presentation and rate of progression.1-4,6,15,16

MPS patients also present oral manifestations that are observed either clinically or radiographically. The accumulation of mucopolysaccharides impacts the stomatognathic system, leading to changes in oral health and to the development of the dentition of patients with this disease.3,7-9,13-15,17-27

Craniofacial features consist of coarse facial features high prominent forehead, snub nose with a depressed nasal bridge, broad nasal tip, and anteverted nostrils.3,7-9,13-15,17-27 Thick lips with an open mouth posture are also features associated with this syndrome.3,7-9,13-15,17-27

Few studies have reported the oral and dental changes in MPS patients. The reported alterations include a short and broad mandible, macroglossia, anterior open-bite, high arched palate with pronounced rugae, spaced dentition, lip hypotonia, gingival hyperplasia and enlargement of the alveolar process. Teeth have been described as misshapen, peg-shaped, small, mal-formed, short, and hypoplastic. Radiographic features that have been reported include short mandibular rami with abnormal condyles; reports also include delayed eruption teeth related to the presence of multiple unerupted teeth with large thickened dental follicles secondary to excessive dermatan sulfate and collagen deposition.3,7-9,13-15,17-27

Notwithstanding, to date there are no studies comparing oral features of patients with mucopolysaccharidosis with controls without the disease. The evaluation of dental conditions in patients with MPS is scarce considering that in literature only clinical cases are described. Epidemiological studies with all types of MPS are rare, specially multicenter studies performed for the collection of more comprehensive data. Finally, there are no studies of dental characteristics of patients with mucopolysaccharidosis in Portugal.

So, the present study aimed to evaluate and characterize the prevalence of oral pathology in patients with mucopolysaccharidosis attending a national reference center in Portugal.

 

MATERIAL AND METHODS

This cross-sectional study consisted of twelve MPS patients with a positive diagnosis resulting from an enzyme assay followed at the Metabolic Diseases Unit of Centro Hospitalar de S. João, EPE/Faculty of Medicine, University of Porto and twelve healthy participants followed at the Faculty of Dental Medicine, University of Porto (control group). The age of participants was between five and twenty-eight years. The Ethics Committees of the Faculty of Dental Medicine and of the Centro Hospitalar de S. João approved the research project. All participants or their parents/legal guardians signed an informed, free and clear consent. Storage and processing of data guaranteed confidentiality of all information, thereby respecting the rules of conduct expressed in the Declaration of Helsinki.

The clinical oral evaluation was performed by a complete extra- and intra-oral examination to assess the presence of oral pathologies and occlusion status. Experienced examiners carried out dental caries examinations, using a mirror and explorer in accordance with World Health Organization criteria and methods. The total number of decayed, missing and filled primary (dmft) and permanent (DMFT) teeth was recorded for each included patient and control. The gingival index was made with a periodontal probe only to determine whether bleeding of dental surfaces occurred after 15 seconds of the sounding. Dental eruption delay was analyzed based on normal age of eruption of permanent teeth and on hospital medical records, when available.

Statistical analysis

Analyses were performed using the Statistical Package for Social Sciences (SPSS) 21.0 for MAC OS. The categorical variables were summarized as relative and absolute frequencies (%) and the continuous variables were described using mean and standard deviation. When appropriate, the chi-squared independence test was used to analyze hypotheses regarding the categorical variables; when expected counts were less then five, Fisher´s test was applied. Student's t-Test was used to evaluate differences between means of continuous variables. A level of 0.05 was considered significant.

 

RESULTS

MPS patients and controls presented similar age (16.5±7.5 vs. 14.4±6.3 years old, p=0.506) and sex distribution (50% males for MPS and 67% males for controls, p=0.637). The MPS group included one patient with MPS I, one patient with MPS II, one with MPS IIIC, one with MPS IV and eight patients with MPS VI.

Regarding oral hygiene all participants declared that they brush their teeth daily. The first dental appointment occurred before 4 years of age in 57% of the MPS children and in 43% of the controls (p = 0.629). Moreover, the percentage of participants attending dental appointments between 5 and 12 years old was also similar between groups (50% vs 50%, p > 0.99).

In comparison to the control group, MPS patients presented greater prevalence of hypoplasia, higher prevalence of delayed tooth eruption, and macroglossia, among other anomalies, as shown in Table 1.

 

 

The presence of anterior open bite, posterior cross bite and limitation of mouth opening are shown in Table 2. MPS patients presented a very high prevalence of anterior open bite and a limitation of mouth opening vs. zero prevalence in controls.

 

 

Although no differences were observed in the Decay-missing-filled-teeth (DMFT) index, MPS patients presented significantly greater prevalence of decayed teeth, but a lower, non-significant prevalence of filled teeth than the control group, as shown in table 3.

 

 

Finallly, we found a significantly higher prevalence of gingival bleeding in the MPS in comparison to controls as shown in Figure 1.

 


Figure 1 - Gingival Bleeding Index in mucopolysaccharidosis (MPS) patients and healthy controls.

 

DISCUSSION

The accumulation of mucopolysaccharides impacts the stomatognathic system, causing changes in oral health and in the dentition of patients with this disease. The extent of the oral affections depends on the severity of the disease and the general state of health of the patient, and this will, in turn, impact upon oral care.8,21,22 Our results showed a greater prevalence of macroglosia and lingual interposition in patients with mucopolysaccharidosis, which is corroborated in the literature by several authors.7,9,13-15,20-24,26-29 The macroglossia is due to the deposition of glycosaminoglycans (GAG) in the tongue structure that usually results in an anterior open bite.7,9,13,15,19-28,30,31 The higher prevalence of lingual interposition in patients with MPS may be due to the presence of macroglossia, anterior open bite and strong maxillary compression.14 Similarly Turra et al14 report the presence of lingual interposition in thirty-four participants of their study, being more frequent in the type VI.

MPS patients showed alteration of tooth shape and size, accompanied by hypoplastic teeth and delayed tooth eruption. McGovern et al22 clinically detected the reduced size of permanent teeth in thirteen patients out of a total of seventeen, with an average of five affected teeth.

It has been suggested that enamel hypoplasia might be due to the random arrangement of materials, as a result of the irregular presence of glycosaminoglycans.8,9,19,22,24,25

Delayed tooth eruption can be explained by the presence of hyperplastic dental follicles due to excessive deposition of collagen and glycosaminoglycans around unerupted teeth17,18,28,32 and also due to dentigerous cysts with smooth and clearly defined margins, as described by Alpôz et al.28

Through the evaluation of dental occlusion, we showed that MPS patients presented anterior open bite, right and left posterior cross-bites, limitation of mouth opening as well as maxillary compression in comparison to controls. Other studies corroborate these findings such as the study of Turra et al14 that followed seventy-eight patients with MPS: 84.8% had anterior open bite, 37.9% had crossbite. Open bite and crossbite are explained by the presence of macroglossia and reverse swallowing.7,9,14,19,22,24,27,30 Similar results were reported in the study by Antunes et al,9 in which five participants in a total of twelve patients showed limitation of mouth opening. This limitation may be due to the presence of condylar defects.7,9,14,19-22,24,25,27,28,30

Our study found that 75% patients with MPS had a higher incidence of bleeding gums in over 30% of the tooth surfaces, corroborating the marginal gingivitis previously described in MPS patients associated with a poor oral hygiene and limited manual dexterity.7-9,13,19,21-24 These findings are possibly related with tissue changes that occur in mucopolysaccharidosis, but also with other factors including difficulty in maintaining oral hygiene, lack of brushing techniques, poor attendance to dentist and lack of collaboration. In MPS patients a greater involvement of dentists is required, in order to arrive at better diagnostics and preventive protocols to improve oral health of these patients.8,9,13,15,20,21,27,33,34

 

SUMMARY

Patients with mucopolysaccharidosis have a high prevalence of eruption delay, teeth morphology alterations, occlusal problems, dental caries and bleeding gums, highlighting the need of oral health care providers to improve diagnostics and preventive protocols to overcome the factors that limit the oral health of these patients and promote together with parent/caregiver efficient oral care strategies.

 

ACKNOWLEDGMENTS

The Faculty of Dental Medicine of the University of Porto, Portugal, supported this investigation. We thank all patients and their families for their availability to participate in the study.

 

CONFLICT OF INTEREST

The authors declare no conflict of interest relative to this project.

 

AUTHOR CONTRIBUTION

All the authors reviewed the literature and conceived the study. Ponciano was involved in patient selection, monitoring and data collection at S. João-Porto Hospital. Ponciano and Areias were involved in patient selection, monitoring and data collection at Faculty of Dental Medicine. All the authors performed the statistical analysis, wrote and revised the manuscript.

 

REFERENCES

1. Neufeld E, Muenzer J. The mucopolysaccharidosis. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8 ed. New York: McGraw-Hill Co; 2001. p. 3421-52.

2. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr. 2004;44(5 Suppl):S27-34. DOI:10.1016/j.jpeds.2004.01.052.

3. Giugliani R, Harmatz P, Wraith JE. Management Guidelines for Mucopolysaccharidosis VI. Pediatrics 2007;120(2):405-18. DOI:10.1542/peds.2006-2184.

4. Muenzer J, Wraith J, Clarke L. Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics. 2009;123(1):19-29. DOI:10.1542/peds.2008-0416.

5. Giugliani R, Federhen A, Rojas M, Vieira T, Artilágas O, Pinto L, et al. Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment. Genet Mol Biol. 2010;33(4):589-604. DOI:10.1590/S1415-47572010005000093.

6. Scarpa M, Almássy Z, Beck M, Bodamer O, Bruce IA, Meirleir LD, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;72(6):1-18. DOI:10.1186/1750-1172-6-72.

7. Almeida-Barros RQ, Oka SCR, Pordeus ACB, Medeiros PFV, Bento PM, Godoy GP. Oral and systemic manifestations of mucopolysaccharidosis type VI: A report of seven cases. Quintessence Int 2012;43(3):e32-8.

8. James A, Hendriksz C, Addison O. The Oral Health Needs of Children, Adolescents and Young Adults Affected by a Mucopolysaccharide Disorder. JIMD Reports. 2012;2:51-8.

9. Antunes LAA, Nogueira APB, Castro GF, Ribeiro MG, Souza IPR. Dental findings and oral health status in patients with mucopolysaccharidosis: a case series. Acta Odontol Scand. 2013;71(1):157-67. DOI:10.3109/00016357.2011.654255.

10. Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet. 1997;101(3)355–8. DOI:10.1007/s004390050641.

11. Baehner F, Shmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005;28(6):1011-7. DOI:10.1007/s10545-005-0112-z.

12. Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M, et al. Newborn screening and diagnosis of mucopolysaccharidoses. Mol Genet Metab. 2013;110(1-2):42-53. DOI:10.1016/j.ymgme.2013.06.007.

13. Junior W, Paiva T, Souza D. Manifestações da Síndrome de Hurler. ConScientiae Saúde. 2009;8(2):317-26.

14. Turra G, Schwartz I. Evaluation of orofacial motricity in patients with mucopolysaccharidosis: a cross-sectional study. J Pediatr (Rio J). 2009;85(3):254-60. DOI:10.2223/JPED.1899.

15. Macedo A, Morais G, Leite F, Rêgo D, Lacerda-Pinheiro S. Mucopolissacaridose tipo I : perfil sistêmico e conduta odontológica do hospital de pediatria da Universidade Federal do Rio Grande do Norte. Int J Dent. 2011;10(3):173-9.

16. Ard JL Jr, Bekker A, Frempong-Boadu AK.. Anesthesia for an adult with mucopolysaccharidosis I. Journal of Clinical Anesthesia. 2005;17(8):624-6. DOI:10.1016/j.jclinane.2005.01.012.

17. Nakamura T, Miwa K, Kanda S, Nonaka K, Anan H, Higash S, et al. Rosette formation of impacted molar teeth in mucopolysaccharidoses and related disorders. Dentomaxillofac Radiol 1992;21(1):45-9. DOI:10.1259/dmfr.21.1.1397452

18. Smith K, Hallett K, Hall R, Wardrop R, Firth N. Mucopolysaccharidosis:MPS Vl and associated delayed tooth eruption. Int J Oral Maxillofac Surg 1995;24(2):176-80.

19. Guven G, Cehreli Z, Altun C, Sençimen M, Ide S, Bayari S, et al. Mucopolysaccharidosis type I (Hurler syndrome): oral and radiographic findings and ultrastructural/chemical features of enamel and dentin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(1):72-8. DOI:10.1016/j.tripleo.2007.02.015.

20. Deepak T, Krishna S, Taretia R. Maroteaux-Lamy Syndrome: A rare case of Mucopolysaccharidosis. J Int Oral Health. 2010;2(2):1-5.

21. Guimarães M, Farias S, Costa A, Amorim Rd. Maroteaux–Lamy Syndrome: Orofacial Features After Treatment by Bone Marrow Transplant. Oral Health & Preventive Dentistry. 2010;8(2):139-42.

22. McGovern E, Owens L, Nunn J, Bolas A, O'Meara A, Fleming P. Oral features and dental health in Hurler Syndrome following hematopoietic stem cell transplantation. Int J Paediatr Dent. 2010;20(5):322– 9. DOI:10.1111/j.1365-263X.2010.01055.x.

23. Shetty R, Dixit U, Hegde R, Shivprakash P. RURS' elbow guard: An innovative treatment of the thumb-sucking habit in a child with Hurler's syndrome. J Indian Soc Pedod Prev Dent. 2010 Jul-Sep;28(3):212-8. DOI:10.4103/0970-4388.73796.

24. Wadenya R, Stout A, Gupta A, Monge J. Hurler syndrome: a case report of a 5-year follow-up of dental findings after bone marrow transplantation. Spec Care Dentist. 2010;30(1):14-7. DOI:10.1111/j.1754-4505.2009.00115.x.

25. Gajula P, Ramalingam K, Bhadrashetty D. A rare case of mucopolysaccharidosis : Hunter Syndrome. J Nat Sci Biol Med. 2012;3(1):97-100. DOI: 10.4103/0976-9668.95984

26. Sharma S, Sabharwal J, Datta P, Sood S. Clinical manifestation of Hurler syndrome in a 7 year old child. Contemp Clin Dent. 2012 Jan;3(1):86-9. DOI:10.4103/0976-237X.94554.

27. Kantaputra P, Kayserili H, Guven Y, Kantaputra W, Balci M, Tanpaiboom P, et al. Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI. J Inherit Metab Dis. 2014;37(2):263-8. DOI:10.1007/s10545-013-9645-8.

28. Alpôs A, Çoker M, Çelen E, Ersin N, Gokçen D, Diggelen O, et al. The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(5):632-7. DOI:10.1016/j.tripleo.2005.06.023.

29. Tatapudi R, Gunashekhar M, Raju S. Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report. Contemp Clin Dent. 2011;2(1):66-8. DOI:10.4103/0976-237X.79287.

30. Hingston E, Hunter M, Hunter B, Drage N. Hurler's syndrome: dental findings in a case treated with bone marrow transplantation in infancy. Int J Paediatr Dent. 2006;16(3):207–12. DOI:10.1111/j.1365-263X.2006.00712.x'

31. Amorín M, Carlin A, Prötzel A. Mucopolisacaridosis de tipo I Hurler: Informe de un caso. Arch Argent Pediatr. 2012;110(5):e130-6. DOI:10.5546/aap.2012.e103

32. Cawson R. The oral changes in gargolysm. Proc R Soc Med. 1962;55(1):1066-70.

33. Cornejo L, Brunotto M, Hilas E. Salivary factors associated to the prevalence and increase of dental caries in rural schoolchildren. Rev Saude Publica. 2008;42(1):19-25. DOI:10.1590/S0034-89102008000100003

34. Ponciano S, Areias C, Leão-Teles E, Sampaio-Maia B. Hyposalivation, acidic saliva, decayed teeth and oral yeast prevalence in children with mucopolysaccharidosis. Medical Express. 2015;2(5):M150502. DOI:10.5935/MedicalExpress.2015.05.02